Condition: Triple Negative Breast Neoplasms · Sponsor: Universitaire Ziekenhuizen KU Leuven
This study has as goal to evaluate the use of abemaciclib and bicalutamide in androgen receptor positive metastatic triple negative breast cancer.
This description comes directly from the study's public registry record.
Patrick Neven, MD, PhD · +3216344750 · patrick.neven@uzleuven.be
Kristien Borremans, MD · +321647795 · kristien.borremans@kuleuven.be
Always discuss trial participation with your own doctor first.
| ZAS Augustinus | Antwerp, Belgium | Recruiting |
| Antwerp University Hospital | Antwerp, Belgium | Not Yet Recruiting |
| University Hospital Brussels | Brussels, Belgium | Recruiting |
| Ghent University Hospital | Ghent, Belgium | Recruiting |
| Jessa Ziekenhuis | Hasselt, Belgium | Recruiting |
| University Hospitals Leuven | Leuven, Belgium | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06365788